FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma

Biography

contributor

Principal Investigator

Overview

sponsor award id

R01CA160495

Time

start date

2012-06-01

end date

2023-07-31

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement